Interstitial lung disease before and after COVID-19: A double threat?

Claudia Valenzuela; Grant Waterer; Ganesh Raghu

doi:10.1183/13993003.01956-2021

Interstitial lung disease before and after COVID-19: A double threat?

Claudia Valenzuela
, Grant Waterer
, Ganesh Raghu

Internal Medicine

Research output: Contribution to journal › Review article › peer-review

38 Citations (Web of Science)

Abstract

Pre-existing ILD and pulmonary fibrosis increases the risk to manifest severe COVID-19. Residual interstitial lung changes and sequelae have been observed in COVID-19 survivors. A closer and standardised long-term follow-up of these patients is needed.

Original language	English
Article number	2101956
Journal	European Respiratory Journal
Volume	58
Issue number	6
DOIs	https://doi.org/10.1183/13993003.01956-2021
Publication status	Published - 1 Dec 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1183/13993003.01956-2021Licence: CC BY-NC

Cite this

@article{916844a659594dce875d4b7a1662ed96,

title = "Interstitial lung disease before and after COVID-19: A double threat?",

abstract = "Pre-existing ILD and pulmonary fibrosis increases the risk to manifest severe COVID-19. Residual interstitial lung changes and sequelae have been observed in COVID-19 survivors. A closer and standardised long-term follow-up of these patients is needed. ",

author = "Claudia Valenzuela and Grant Waterer and Ganesh Raghu",

year = "2021",

month = dec,

day = "1",

doi = "10.1183/13993003.01956-2021",

language = "English",

volume = "58",

journal = "European Respiratory Journal",

issn = "0903-1936",

publisher = "European Respiratory Society",

number = "6",

}

TY - JOUR

T1 - Interstitial lung disease before and after COVID-19

T2 - A double threat?

AU - Valenzuela, Claudia

AU - Waterer, Grant

AU - Raghu, Ganesh

PY - 2021/12/1

Y1 - 2021/12/1

N2 - Pre-existing ILD and pulmonary fibrosis increases the risk to manifest severe COVID-19. Residual interstitial lung changes and sequelae have been observed in COVID-19 survivors. A closer and standardised long-term follow-up of these patients is needed.

AB - Pre-existing ILD and pulmonary fibrosis increases the risk to manifest severe COVID-19. Residual interstitial lung changes and sequelae have been observed in COVID-19 survivors. A closer and standardised long-term follow-up of these patients is needed.

UR - https://www.scopus.com/pages/publications/85120934481

U2 - 10.1183/13993003.01956-2021

DO - 10.1183/13993003.01956-2021

M3 - Review article

C2 - 34857587

AN - SCOPUS:85120934481

SN - 0903-1936

VL - 58

JO - European Respiratory Journal

JF - European Respiratory Journal

IS - 6

M1 - 2101956

ER -

Interstitial lung disease before and after COVID-19: A double threat?

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this